- / Aug 07, 2024 / Business Wire / The UnitedHealth Group (NYSE: UNH) board of directors has authorized payment of a cash dividend of $2.10 per share, to be paid on September 24, 2024, to all shareholders of record of UNH common stock as of the close of business September 16, 2024.
About UnitedHealth Group
UnitedHealth Group (NYSE: UNH) is a health care and well-being company with a mission to help people live healthier lives and help make the health system work better for everyone through two distinct and complementary businesses. Optum delivers care aided by technology and data, empowering people, partners and providers with the guidance and tools they need to achieve better health. UnitedHealthcare offers a full range of health benefits, enabling affordable coverage, simplifying the health care experience and delivering access to high-quality care. Visit UnitedHealth Group at www.unitedhealthgroup.com and follow UnitedHealth Group on LinkedIn.
| Last Trade: | US$500.70 |
| Daily Change: | 11.45 2.34 |
| Daily Volume: | 9,403,075 |
| Market Cap: | US$460.780B |
October 15, 2024 July 16, 2024 May 23, 2024 September 12, 2023 August 17, 2023 | |
Immix Biopharma is a clinical-stage biopharmaceutical company pioneering a novel class of CAR-T cell therapies and Tissue-Specific Therapeutics targeting oncology and immuno-dysregulated diseases with >75 patients treated to-date. Our lead cell therapy asset is NXC-201...
CLICK TO LEARN MORE
Chimerix is on a mission to develop medicines that meaningfully improve and extend the lives of patients facing deadly diseases. The company is devoted to filling gaps in the treatment paradigm. Chimerix’s most advanced clinical-stage program is in development for H3 K27M-mutant glioma....
CLICK TO LEARN MORE
